NRL News
202.626.8824
dadandrusk@aol.com

Abortion clinic representatives ask judge to shield them from further limitations on their use of mifepristone

by | Jun 15, 2023

“Specifically, providers want the FDA and U.S. Department of Health and Human Services to abandon the set of restrictions known as a Risk Evaluation and Mitigation Strategy (“REMS”), which has applied to mifepristone since it was approved 23 years ago,” according to Whittney Evans. “REMS regulates mifepristone in a similar way to chemotherapy drugs, which providers argue is unnecessary and misleading.”

What the providers ultimately want “is for the federal government to remove the REMS designation entirely,” Evans continued. “In the meantime, they’ve asked District Judge Robert S. Ballou for a preliminary injunction to prevent further restrictions and maintain the status quo.”

Read the whole story.

Categories: Abortion Clinic
Tags: